Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 2, 1999
Using pharmacodynamic and pharmacokinetic surrogate markers in clinical practice: optimizing antimicrobial therapy in respiratory-tract infectionsD P NicolauThe Journal of Infection|August 2, 2002
Pharmacodynamic rationale for short-duration antibacterial therapyD P NicolauThe American Journal of Managed Care|September 8, 2000
The challenge of prescribing treatment for respiratory tract infectionsD P NicolauThe American Journal of Managed Care|February 24, 2001
Antibiotic kinetic and dynamic attributes for community-acquired respiratory tract infectionsD P NicolauInfection|January 12, 2002
Predicting antibacterial response from pharmacodynamic and pharmacokinetic profilesD P NicolauPharmacoeconomics|December 9, 1993
Choosing between the new cephalosporin antibiotics: a pharmacodynamic approachD P Nicolau, R QuintilianiMethods and Findings in Experimental and Clinical Pharmacology|January 27, 2005
The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimensD Maglio, D P NicolauAntimicrobial Agents and Chemotherapy|November 2, 2016
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coliM L Monogue, D P NicolauThe American Journal of Medicine|January 5, 2002
Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniaeD P Nicolau, P G AmbroseDICP : the Annals of Pharmacotherapy|November 1, 1990
Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDSD P Nicolau, T E WestPageof 19